233 related articles for article (PubMed ID: 14961574)
21. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
22. Dysplastic lipoma: potential diagnostic pitfall of using MDM2 RNA in situ hybridization to distinguish between lipoma and atypical lipomatous tumor.
Hung YP; Michal M; Dubuc AM; Rosenberg AE; Nielsen GP
Hum Pathol; 2020 Jul; 101():53-57. PubMed ID: 32439322
[TBL] [Abstract][Full Text] [Related]
23. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
24. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
[TBL] [Abstract][Full Text] [Related]
25. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas?
Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F
Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
[TBL] [Abstract][Full Text] [Related]
27. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
28. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
Pedeutour F; Maire G; Sirvent N;
Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
[TBL] [Abstract][Full Text] [Related]
29. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
Forus A; Flørenes VA; Maelandsmo GM; Meltzer PS; Fodstad O; Myklebost O
Cell Growth Differ; 1993 Dec; 4(12):1065-70. PubMed ID: 8117620
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
[TBL] [Abstract][Full Text] [Related]
31. Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization.
Farshid G; Otto S; Collis M; Napper S; Nicola M
Appl Immunohistochem Mol Morphol; 2023 Feb; 31(2):101-106. PubMed ID: 36692149
[TBL] [Abstract][Full Text] [Related]
32. MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?
Gruel N; El Zein S; Tzanis D; Nicolas N; Maraval A; Fieffe C; Bonvalot S; Caly M; Fuhrmann L; Ait Rais K; Jovelin S; Bonnet C; Pierron G; Watson S
Genes Chromosomes Cancer; 2023 Jun; 62(6):367-372. PubMed ID: 36744846
[TBL] [Abstract][Full Text] [Related]
33. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.
Meza-Zepeda LA; Forus A; Lygren B; Dahlberg AB; Godager LH; South AP; Marenholz I; Lioumi M; Flørenes VA; Maelandsmo GM; Serra M; Mischke D; Nizetic D; Ragoussis J; Tarkkanen M; Nesland JM; Knuutila S; Myklebost O
Oncogene; 2002 Mar; 21(14):2261-9. PubMed ID: 11948409
[TBL] [Abstract][Full Text] [Related]
34. Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors.
Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
36. Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomas.
Nord KH; Macchia G; Tayebwa J; Nilsson J; Vult von Steyern F; Brosjö O; Mandahl N; Mertens F
Hum Mol Genet; 2014 Feb; 23(4):878-88. PubMed ID: 24070870
[TBL] [Abstract][Full Text] [Related]
37. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors.
Trombetta D; Mertens F; Lonoce A; D'Addabbo P; Rennstam K; Mandahl N; Storlazzi CT
Genes Chromosomes Cancer; 2009 Nov; 48(11):993-1001. PubMed ID: 19691106
[TBL] [Abstract][Full Text] [Related]
39. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma.
Pedeutour F; Suijkerbuijk RF; Forus A; Van Gaal J; Van de Klundert W; Coindre JM; Nicolo G; Collin F; Van Haelst U; Huffermann K
Genes Chromosomes Cancer; 1994 Jun; 10(2):85-94. PubMed ID: 7520271
[TBL] [Abstract][Full Text] [Related]
40. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
